The roles of nitric oxide and hydrogen sulfide in the anti-atherosclerotic effect of atorvastatin

Journal of Cardiovascular Medicine

Volumn 16, Issue 1, 2015, Pages 22-28

  Liu, Xing ^a   Ma, Dongming ^b   Zheng, Shuzhan ^a   Zha, Kelan ^a   Feng, Jian ^a   Cai, Yihua ^a   Jiang, Feng ^a   Li, Jiafu ^a   Fan, Zhongcai ^a  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

^b Department of Cardiology Santai People's Hospital   (China)

Author keywords

Atherosclerosis; Atorvastatin; Hydrogen sulfide; Nitric oxide

Indexed keywords

ATORVASTATIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROGEN SULFIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROPARGYLGLYCINE; TRIACYLGLYCEROL; ALKYNE; GLYCINE; HEPTANOIC ACID DERIVATIVE; PYRROLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIATHEROSCLEROSIS ACTIVITY; AORTA ARCH; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DESCENDING AORTA; DRUG ACTIVITY; LIPID DIET; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; DRUG EFFECTS; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; THORACIC AORTA;

ALKYNES; ANIMALS; AORTA, THORACIC; ATHEROSCLEROSIS; DIET, HIGH-FAT; GLYCINE; HEPTANOIC ACIDS; HYDROGEN SULFIDE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PYRROLES; RATS, SPRAGUE-DAWLEY;

EID: 84918811879     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0000000000000012     Document Type: Article

References (22)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340:115-126.
2. Yildirir A, Müderrisoglu H. Nonlipid effects of statins: emerging new indications. Curr Vasc Pharmacol 2004; 2:309-318.
3. Bonetti PO, Lerman LO, Napoli C, Lerman A. Statin effects beyond lipid lowering: Are they clinically relevant? Eur Heart J 2003; 24:225- 248.
4. Sorrentino S, Landmesser U. Nonlipid-lowering effects of statins. Curr Treat Options Cardiovasc Med 2005; 7:459-466.
5. Kaesemeyer WH, Caldwell RB, Huang J, Caldwell RW. Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions. J Am Coll Cardiol 1999; 33:234- 241.
6. Searles CD. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression. Am J Physiol Cell Physiol 2006; 291:C803-C816.
7. Mehta JL, Li D. Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor. J Am Coll Cardiol 2002; 39:1429-1435.
8. Bell RM, Yellon DM. Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up regulating a pro-survival pathway. J Am Coll Cardiol 2003; 41:508- 515.
9. Leffler CW, Parfenova H, Jaggar JH, Wang R. Carbon monoxide and hydrogen sulfide: gaseous messengers in cerebrovascular circulation. J Appl Physiol 2006; 100:1065-1076.
10. Li W, Tang C, Jin H, Du J. Effects of onion extract on endogenous vascular H2S and adrenomedulin in rat atherosclerosis. Curr Pharm Biotechnol 2011; 12:1427-1439.
11. Wang Y, Zhao X, Jin H, et al. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipo-protein E knockout mice. Arterioscler Thromb Vasc Biol 2009; 29:173-179.
12. Zhi L, Ang AD, Zhang H, et al. Hydrogen sulfide induces the synthesis of pro inflammatory cytokines in human monocyte cell line U937 via the ERKNF- kappa B pathway. J Leukoc Biol 2007; 81:1322-1332.
13. Kenneth J, Livak. Schmittgen TD. Analysis of relative gene expression data using real -time quantitative PCR and the 2-DDCT methods. Methods 2001; 25:402-408.
14. Ponnuswamy P, Schröttle A, Ostermeier E, et al. eNOS protects from atherosclerosis despite relevant superoxide production by the enzyme in apoE mice. PLoS One 2012; 7:e30193.
15. Projahn D, Koenen RR. Platelets: key players in vascular inflammation. J Leukoc Biol 2012; 92:1167-1175.
16. Karshovska E, Weber C. Atherosclerosis: cell biology and lipoproteins: new mechanistic links in atherosclerosis: chemokines mediating the effects of lipids, platelets and dendritic cells. Curr Opin Lipidol 2012; 23:400-401.
17. Verhaar MC, Westerweel PE, van Zonneveld AJ, Rabelink TJ. Free radical production by dysfunctional eNOS. Heart 2004; 90:494-495.
18. Umansky V, Schirrmacher V. Nitric oxide-induced apoptosis in tumor cells. Adv Cancer Res 2001; 82:107-131.
19. Akaike T, Okamoto T, Zaki MH, et al. New paradigm of host defense against intracellular pathogens by nitric oxide. Nihon Hansenbyo Gakkai Zasshi 2009; 78:41-47.
20. Sun Y, Tang CS, DU JB, Jin HF. Hydrogen sulfide and vascular relaxation. Chin Med J 2011; 124:3816-3819.
21. Yang G, Sun X, Wang R. Hydrogen sulfide-induced apoptosis of human aorta smooth muscle cells via the activation of mitogen-activated protein kinases and caspase-3. FASEB J 2004; 18:1782-1784.
22. Rong-na L, Xiang-jun Z, Yu-han C, et al. Interaction between hydrogen sulfide and nitric oxide on cardiac protection in rats with metabolic syndrome. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2011; 33:25-32.